PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
54,555,170
Share change
-3,640,413
Total reported value
$474,625,571
Put/Call ratio
37%
Price per share
$8.70
Number of holders
113
Value change
-$38,255,414
Number of buys
46
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2022

As of 31 Dec 2022, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,555,170 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, JPMORGAN CHASE & CO, BlackRock Inc., STATE STREET CORP, Boxer Capital, LLC, Avoro Capital Advisors LLC, VANGUARD GROUP INC, Euclidean Capital LLC, and INTERWEST VENTURE MANAGEMENT CO. This page lists 113 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.